Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mankind Pharma Ltd.

www.mankindpharma.com

Latest From Mankind Pharma Ltd.

Curatio Nets $20m Investment As Dermatology Stays On PE Menu

Private equity group ChrysCapital is investing $20m in the Indian firm Curatio Healthcare, underscoring the continuing interest in the niche dermatology space that generally sees healthy margins.

Commercial Strategy

M&A Trends: The Growing Indian Appetite

A recent round table on pharma industry trends has highlighted the hunger of cash-rich Indian firms for acquiring companies with niche portfolios in regulated markets including the US. Innovator companies shedding their generic units also present significant opportunities for Indian firms. Both trends are expected to build amid apparent Indian interest in the Teva-Allergan divestiture in Europe.

Commercial Deals

Indian Market Gains Momentum With Strong Growth In April

The Indian pharmaceutical market saw 17% growth last month, backed by an uptick in both chronic and acute therapy products. But industry experts are cautioning of uncertainties related to drug pricing policy.

BioPharmaceutical Asia Pacific

ANALYSIS: Will Sun-Ranbaxy Pairing Trigger More M&As In India?

The Indian pharmaceutical market is seeing a decisive shift. Starting now, Sun and Ranbaxy as a combined organization will dislodge Abbott from its top position held for over five years. Will companies respond with more merger deals or stay with incremental organic growth?

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Mankind Pharma Ltd.
  • Senior Management
  • R.C. Juneja, Mng. Dir.
  • Contact Info
  • Mankind Pharma Ltd.
    Phone: (91) 66608088
    236, Okhla, Phase -III
    New Delhi,
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register